Reports for SANDOZ CANADA INCORPORATED
Company Name
SANDOZ CANADA INCORPORATED
Totals |
||
Shortage reports |
2123 |
|
| Actual shortage: | 50 (2%) | |
| Anticipated shortage: | 9 (0%) | |
| Avoided shortage: | 19 (1%) | |
| Resolved: | 2045 (96%) | |
Discontinuation Reports |
101 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 98 (97%) | |
| Reversed: | 2 (2%) | |
Late reports |
444 (20%) |
|
Overdue reports |
38 (63%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ D-FORTE | 50000UNIT | CAPSULE | Resolved | 2022-02-24 | 2022-03-11 | 155505 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Actual shortage | 2025-05-05 | 2025-05-06 | 256661 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-08-21 | 2023-11-13 | 202538 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-09-05 | 2023-10-17 | 203653 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2023-11-20 | 2024-01-17 | 210838 |
| SANDOZ DAPAGLIFLOZIN | 5MG | TABLET | Resolved | 2023-12-19 | 2024-01-04 | 213801 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2024-01-16 | 2024-02-06 | 216168 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2024-03-05 | 2024-05-14 | 221380 |
| SANDOZ DAPAGLIFLOZIN | 10MG | TABLET | Resolved | 2024-07-02 | 2024-08-13 | 231744 |
| SANDOZ DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Resolved | 2021-12-30 | 2022-01-18 | 151976 |
| SANDOZ DEFERASIROX | 125MG | TABLET FOR SUSPENSION | Resolved | 2020-01-08 | 2020-03-30 | 102568 |
| SANDOZ DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Resolved | 2023-06-05 | 2023-10-24 | 193710 |
| SANDOZ DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Resolved | 2023-09-19 | 2023-11-14 | 204727 |
| SANDOZ DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2022-02-17 | 2022-02-25 | 155256 |
| SANDOZ DEFERASIROX (TYPE J) | 360MG | TABLET | Resolved | 2024-04-23 | 2024-06-26 | 225962 |
| SANDOZ DEFERASIROX (TYPE J) | 360MG | TABLET | Resolved | 2024-11-25 | 2025-04-22 | 243843 |
| SANDOZ DEFERASIROX (TYPE J) | 180MG | TABLET | Resolved | 2025-01-13 | 2025-04-22 | 247593 |
| SANDOZ DEFERASIROX (TYPE J) | 90MG | TABLET | Resolved | 2025-04-07 | 2025-04-22 | 254335 |
| SANDOZ DICLOFENAC OPHTHA | 0.1% | SOLUTION | Resolved | 2022-06-03 | 2022-06-09 | 161791 |
| SANDOZ DICLOFENAC OPHTHA | 0.1% | SOLUTION | Resolved | 2020-12-21 | 2021-01-12 | 130505 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALFENTANIL INJECTION USP | Discontinued | 2019-10-15 | 2019-10-15 | 96610 | ||
| ATRACURIUM BESYLATE INJECTION | Discontinued | 2019-10-15 | 2019-10-15 | 96613 | ||
| BETAJECT | Discontinued | 2019-10-15 | 2019-10-15 | 96616 | ||
| BLUE COLLYRIUM | Discontinued | 2019-10-15 | 2019-10-15 | 96619 | ||
| BRETYLIUM TOSYLATE INJECTION USP | Discontinued | 2020-04-01 | 2020-04-01 | 110288 | ||
| BRETYLIUM TOSYLATE INJECTION USP | 50MG | SOLUTION | Discontinued | 2017-12-06 | 2017-12-06 | 31958 |
| CLINDAMYCIN INJECTION USP | 150MG | LIQUID | Discontinued | 2017-06-06 | 2017-10-18 | 12122 |
| CODEINE PHOSPHATE INJECTION USP | 30MG | LIQUID | Discontinued | 2022-04-20 | 2022-04-20 | 159064 |
| COMTAN | 200MG | TABLET | Discontinued | 2022-03-03 | 2022-03-04 | 155940 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Discontinued | 2018-08-27 | 2019-01-02 | 59179 |
| FOLIC ACID INJECTION USP | 5MG | LIQUID | To be discontinued | 2019-05-01 | 2019-05-01 | 82956 |
| FOLIC ACID INJECTION USP | 5MG | LIQUID | Discontinued | 2020-01-28 | 2020-01-28 | 104481 |
| HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) | 10000UNIT | SOLUTION | Discontinued | 2018-07-04 | 2018-07-31 | 54349 |
| HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | 10000UNIT | SOLUTION | Discontinued | 2024-05-17 | 2024-05-18 | 228249 |
| HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | 10000UNIT | SOLUTION | Discontinued | 2023-10-18 | 2023-10-19 | 207275 |
| IMIPENEM AND CILASTATIN FOR INJECTION USP | 250MG 250MG | POWDER FOR SOLUTION | Discontinued | 2021-08-23 | 2021-08-23 | 144467 |
| LORAZEPAM INJECTION USP | 2MG | SOLUTION | Discontinued | 2020-02-14 | 2020-03-12 | 106265 |
| MICRO PLUS 6 (CONCENTRATE) | 75MCG 60MCG 10MCG 0.5MG 1MG 5MG | LIQUID | Discontinued | 2021-10-25 | 2021-10-26 | 147927 |
| MILRINONE LACTATE INJECTION | 1MG | SOLUTION | Discontinued | 2022-06-17 | 2022-06-18 | 163000 |
| OLANZAPINE FOR INJECTION | 10MG | POWDER FOR SOLUTION | Discontinued | 2020-06-22 | 2020-06-22 | 118553 |